KPIs & Operating Metrics(New)

Balance Sheet

Accounts Payables Accumulated Expenses Assets Capital Leases Cash & Current Investments Cash & Equivalents Common Equity Curent Deferred Tax Liability Current Assets Current Deferred Revenue Current Deferred Tax Assets Current Leases Finished Goods Goodwill Goodwill & Intangibles Intangibles Inventory Liabilities and Shareholders Equity Liabilities from Discontinued Operations Long-Term Deferred Tax Long-Term Investments Minority Interest Non-Current Assets Non-Current Debt Non-Current Deferred Tax Liability Non-Current Deffered Revenue Operating Leases Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Pension Prepaid Assets Property, Plant & Equipment (Net)Raw Materials Receivables Receivables - Net Receivables - Other Retained Earnings Shareholder's Equity Short term Debt Short-term Investments Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares Work In Process

Daily Values

Growth Metrics

Others

Charles River Laboratories International (CRL) Current Taxes: 2010-2011

Charles River Laboratories International's Current Taxes was N/A to $8.4 million in Q3 2011 from the same period last year, while for Sep 2011 it was $8.4 million, marking a year-over-year change of. This contributed to the annual value of $18.4 million for FY2010, which is N/A change from last year.
Latest data reveals that Charles River Laboratories International reported Current Taxes of $8.4 million as of Q3 2011, which was down 17.17% from $10.2 million recorded in Q2 2011.
Charles River Laboratories International's Current Taxes' 5-year high stood at $18.4 million during Q4 2010, with a 5-year trough of $8.4 million in Q3 2011.
Moreover, its 2-year median value for Current Taxes was $10.2 million (2011), whereas its average is $12.3 million.